Clinical Trials Browser

Phase 2/3 × Unknown × Peripheral Nervous System Diseases × Clear all

NCT05595109 2022-10-26

Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients

Phase 2/3 Unknown

Breast Neoplasms, Peripheral Nervous System Diseases, Cognitive Dysfunction, Cardiotoxicity

NCT02590367 2015-12-02

Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy

Phase 2/3 Unknown

Gastrointestinal

Peripheral Nervous System Diseases, Colorectal Neoplasms